WATER SOLUBLE FORMS OF RETINOIDS
US Patent 4,371,673
Filed on 1980-07-21
Filed on 1980-07-21
In recognition of pioneering research and development and an unsurpassed commitment to transferring NIH/NIA technology to benefit mankind.
Awardee
National Institute on Aging
Taxus® Express2™ has the potential to benefit many of the victims of cardiovascular disease, which causes 40% of all deaths in the US. After a heart attack, patients often undergo an invasive by-pass surgery or a less invasive angioplasty procedure to open up the clogged artery. In the latter procedure, a tiny meshlike device called a stent is inserted into the artery to keep it propped open. However, in many of the stent placement cases, the body reacts to this foreign object with scar tissue formation and the artery narrows again.